» Articles » PMID: 20580718

Multiple Roles of ATM in Monitoring and Maintaining DNA Integrity

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2010 Jun 29
PMID 20580718
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of our cells to maintain genomic integrity is fundamental for protection from cancer development. Central to this process is the ability of cells to recognize and repair DNA damage and progress through the cell cycle in a regulated and orderly manner. In addition, protection of chromosome ends through the proper assembly of telomeres prevents loss of genetic information and aberrant chromosome fusions. Cells derived from patients with ataxia-telangiectasia (A-T) show defects in cell cycle regulation, abnormal responses to DNA breakage, and chromosomal end-to-end fusions. The identification and characterization of the ATM (ataxia-telangiectasia, mutated) gene product has provided an essential tool for researchers in elucidating cellular mechanisms involved in cell cycle control, DNA repair, and chromosomal stability.

Citing Articles

Mapping chromatin interactions at melanoma susceptibility loci and cell-type specific dataset integration uncovers distant gene targets of -regulation.

Thakur R, Xu M, Sowards H, Yon J, Jessop L, Myers T medRxiv. 2025; .

PMID: 39802764 PMC: 11722502. DOI: 10.1101/2024.11.14.24317204.


ATM deficiency differentially affects expression of proteins related to fatty acid oxidation and oxidative stress in a sex-specific manner in response to Western-type diet prior to and following myocardial infarction.

Wang-Heaton H, Wingard M, Dalal S, Shook P, Connelly B, Johnson P Life Sci. 2024; 342:122541.

PMID: 38428572 PMC: 10949412. DOI: 10.1016/j.lfs.2024.122541.


ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.

Vokes N, Cobo A, Fernandez-Chas M, Molkentine D, Trevino 3rd S, Druker V Clin Cancer Res. 2023; 29(23):4958-4972.

PMID: 37733794 PMC: 10690143. DOI: 10.1158/1078-0432.CCR-23-1122.


Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.

Staudt D, Murray H, Skerrett-Byrne D, Smith N, Jamaluddin M, Kahl R Clin Proteomics. 2022; 19(1):48.

PMID: 36536316 PMC: 9762002. DOI: 10.1186/s12014-022-09385-7.


Analysis of the p53/microRNA Network in Cancer.

Kaller M, Hunten S, Siemens H, Hermeking H Adv Exp Med Biol. 2022; 1385:187-228.

PMID: 36352215 DOI: 10.1007/978-3-031-08356-3_7.


References
1.
Takai H, Smogorzewska A, de Lange T . DNA damage foci at dysfunctional telomeres. Curr Biol. 2003; 13(17):1549-56. DOI: 10.1016/s0960-9822(03)00542-6. View

2.
Goodarzi A, Noon A, Deckbar D, Ziv Y, Shiloh Y, Lobrich M . ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell. 2008; 31(2):167-77. DOI: 10.1016/j.molcel.2008.05.017. View

3.
Shreeram S, Demidov O, Hee W, Yamaguchi H, Onishi N, Kek C . Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell. 2006; 23(5):757-64. DOI: 10.1016/j.molcel.2006.07.010. View

4.
Lavin M . ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene. 2007; 26(56):7749-58. DOI: 10.1038/sj.onc.1210880. View

5.
Schneider J, Finck B, Ren J, Standley K, Takagi M, Maclean K . ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 2006; 4(5):377-89. DOI: 10.1016/j.cmet.2006.10.002. View